"
According to the latest report published by Data Bridge Market Research, the Hypozincemia Drugs Market
Data Bridge Market Research analyses a growth rate in the hypozincemia drugs market in the forecast period 2023-2030. The expected CAGR of hypozincemia drugs market is tend to be around 5% in the mentioned forecast period. The market was valued at USD 500 million in 2022, and it would grow upto USD 738.73 million by 2030.
